Published in Biophys J on February 03, 2015
Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem (2006) 22.87
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science (2003) 18.18
Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science (2000) 6.16
A theory of linear and helical aggregations of macromolecules. J Mol Biol (1962) 4.92
Structural classification of toxic amyloid oligomers. J Biol Chem (2008) 4.16
Analysis of protein aggregation kinetics. Methods Enzymol (1999) 3.97
An analytical solution to the kinetics of breakable filament assembly. Science (2009) 3.87
Mechanism of prion propagation: amyloid growth occurs by monomer addition. PLoS Biol (2004) 3.75
Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry (2001) 3.47
Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly. Proc Natl Acad Sci U S A (2008) 2.90
The importance of sequence diversity in the aggregation and evolution of proteins. Nature (2005) 2.70
Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis. Biochemistry (2002) 2.44
Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology (2006) 2.27
Fibril fragmentation enhances amyloid cytotoxicity. J Biol Chem (2009) 2.13
Nanomechanics of functional and pathological amyloid materials. Nat Nanotechnol (2011) 1.90
Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem (2004) 1.79
Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. ACS Chem Neurosci (2009) 1.75
Fitting neurological protein aggregation kinetic data via a 2-step, minimal/"Ockham's razor" model: the Finke-Watzky mechanism of nucleation followed by autocatalytic surface growth. Biochemistry (2008) 1.60
Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments. J Chem Phys (2011) 1.52
Length dependence of rate constants for end-to-end association and dissociation of equilibrium linear aggregates. Biophys J (1983) 1.27
Nucleated polymerization with secondary pathways. II. Determination of self-consistent solutions to growth processes described by non-linear master equations. J Chem Phys (2011) 1.23
Mechanisms of amyloidogenesis. Nat Struct Biol (2000) 1.17
Secondary nucleation and accessible surface in insulin amyloid fibril formation. J Phys Chem B (2008) 1.05
Relationship between stability of folding intermediates and amyloid formation for the yeast prion Ure2p: a quantitative analysis of the effects of pH and buffer system. J Mol Biol (2003) 1.04
Observation of spatial propagation of amyloid assembly from single nuclei. Proc Natl Acad Sci U S A (2011) 1.04
Apolipoprotein C-II amyloid fibrils assemble via a reversible pathway that includes fibril breaking and rejoining. J Mol Biol (2008) 0.98
Nucleated polymerization with secondary pathways. III. Equilibrium behavior and oligomer populations. J Chem Phys (2011) 0.96
Fitting yeast and mammalian prion aggregation kinetic data with the Finke-Watzky two-step model of nucleation and autocatalytic growth. Biochemistry (2008) 0.92
Modelling amyloid fibril formation kinetics: mechanisms of nucleation and growth. J Phys Condens Matter (2013) 0.87
Mechanistic and environmental control of the prevalence and lifetime of amyloid oligomers. Nat Commun (2013) 0.86
Role of filament annealing in the kinetics and thermodynamics of nucleated polymerization. J Chem Phys (2014) 0.82
Evidence for the existence of a secondary pathway for fibril growth during the aggregation of tau. J Mol Biol (2012) 0.81
Inherent variability in the kinetics of autocatalytic protein self-assembly. Phys Rev Lett (2014) 0.79
Spatial propagation of protein polymerization. Phys Rev Lett (2014) 0.77